iCAD and Google Health are intensifying their partnership to integrate advanced AI technology into the ProFound Breast Health Suite for 2D Mammography. This collaboration aims to facilitate independent reading for breast cancer screening worldwide,…
Continue Reading
What You Should Know:
iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it signed an amendment to its development and commercialization agreement with Google Health, which will…
Continue Reading
AI can leverage low-dose CT scan data of the lungs to enhance risk prediction for mortality from lung cancer and cardiovascular disease, as per a study in Radiology. The AI algorithm automatically derives body…
Continue Reading
Artificial intelligence (AI) based algorithms for classification of suspicious skin lesions have been implemented in mobile phone apps (mHealth), but their effect on healthcare systems is undocumented. In 2019, a large Dutch health insurance…
Continue Reading
The Radiological Society of North America (RSNA) organized the RSNA Screening Mammography Breast Cancer Detection AI Challenge to foster the development of AI models that accurately detect breast cancer. With participation from nearly 1,700…
Continue Reading
Sengkang General Hospital in Singapore is turning into a centre of excellence for AI-assisted colonoscopy with support from Medtronic International.The two organisations have signed a memorandum of understanding to promote AI-assisted colonoscopy for colorectal cancer…
Continue Reading
The latest Digital Health news industry round-up includes an award of £1.4m for Mendelian to further develop its AI solutions, a pilot for a state-of-the-art prehabilitation programme at James Paget University Hospitals and the…
Continue Reading
South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration’s 510(k) clearance for its latest AI-powered analysis software for screening lung nodules.The company develops AI imaging solutions for diagnosing various chest…
Continue Reading
What You Should Know:– C2i Genomics, a cancer intelligence company, today announced a collaboration with Riken Genesis Co., Ltd. (RG), a company specializing in providing the service of personalized medicine based on contract analysis…
Continue Reading
